Medicinal Chemists are specialized scientists focused on the design, synthesis, and development of chemical compounds that can become pharmaceutical drugs. Their work bridges the gap between chemistry and pharmacology, applying principles of organic chemistry to develop molecules that interact with biological systems in therapeutic ways. Medicinal chemists are responsible for optimizing the chemical properties of compounds to improve their effectiveness, stability, and bioavailability. Their goal is to identify molecules that can target specific biological pathways or diseases while minimizing side effects. Through techniques like structure-activity relationship (SAR) analysis, they refine drug candidates to meet the necessary criteria for preclinical and clinical testing. Medicinal chemists are also crucial in addressing emerging healthcare challenges, such as the development of drugs for antibiotic-resistant infections.
Medicinal chemists work closely with pharmacologists, toxicologists, and formulation scientists to ensure the drug candidates are suitable for development. They are involved in every step of the drug discovery process, from the initial hit identification through to lead optimization and scale-up for clinical trials. These chemists also tackle challenges like drug resistance and metabolic degradation, working to create more potent, long-lasting therapies. With the rise of personalized medicine, medicinal chemists are increasingly focused on developing drugs tailored to individual genetic profiles. Their expertise remains essential in driving forward the discovery and development of new, life-saving therapies.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada